Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan Universtiy Shanghai Cancer Centre, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Hongmei Ying, M.D.) · yinghongmei2011@sina.com · +8621-64175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Nasopharyngeal Carcinoma (NPC)

Abroad (travel likely)RecruitingPHASE3

Nanning, China

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Fuzhou, China · Xiamen, China

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · Nasopharyngeal Cancer · Nasopharyngeal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Aachen, Germany · Aachen, Germany

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China